Abstract
Interleukin-6 (IL-6) was recently described to support the growth of Epstein-Barr (EBV) transformed lymphocytes. However no effect was reported on cloning of EBV transformed lymphocytes under limiting dilution conditions. In this paper we demonstrate that the Supernatant of Human Endothelial Cells (HECS) contains a factor(s) different from IL-6 which induces high cloning efficiency of EBV transformed cell lines, cultured under limiting dilution conditions. Furthermore HECS is superior to IL-6 in all the passages of EBV lymphocytes transformation.
Original language | English |
---|---|
Pages (from-to) | 132-133 |
Number of pages | 2 |
Journal | Cytotechnology |
Volume | 5 |
Issue number | 1 Supplement |
DOIs | |
Publication status | Published - Feb 1991 |
ASJC Scopus subject areas
- Clinical Biochemistry
- Cell Biology
- Biotechnology